ISIN | LU0329630130 |
---|---|
Numero di valore | 3535023 |
Bloomberg Global ID | VARMVP2 LX |
Nome del fondo | Variopartner SICAV - MIV Global Medtech Fund P2 |
Offerente del fondo |
MIV Global Medtech Fund
Feldeggstrasse 55 8008 Zürich Schweiz Telefono: +41 44 253 64 11 E-Mail: info@mivam.ch |
Offerente del fondo | MIV Global Medtech Fund |
Rappresentante in Svizzera |
Vontobel Fonds Services AG Zürich Telefono: +41 58 283 74 77 |
Distributore(i) |
Vontobel Fonds Services AG Zürich Telefono: +41 58 283 74 77 |
Asset class | Fondi azionari |
EFC Categoria | Equity Health Care |
Classe di quote | Accumulation |
Paese di domicilio | Lussemburgo |
Condizioni all-unknown-emissione | Nessuna commissione di emissione e/o altre commissioni a favore del fondo (emissione al valore d’inventario) |
Condizioni al riscatto | Nessuna commissione di riscatto e/o altre commissioni a favore del fondo (riscatto al valore d’inventario) |
Strategia d'investimenti *** | This Sub-Fund aims to achieve maximum capital growth by means of investments in the sector of medical technology worldwide. In order to achieve this, and taking account of the principle of risk diversification, a minimum of two-thirds of the SubFund’s total assets are invested directly in equities, equity-like transferable securities, participation certificates, depositary receipts, such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs) referring to such securities, etc. from issuers worldwide, mainly active in the sector of medical technology. Besides this, up to one third of the total assets of the Sub-Fund may be invested in participation securities from companies that are not or not principally active in the sector of medical technology. |
Particolarità |
Prezzo attuale * | 2'521.07 EUR | 31.10.2024 |
---|---|---|
Prezzo precedente * | 2'556.02 EUR | 30.10.2024 |
Max 52 settimani * | 2'624.67 EUR | 18.10.2024 |
Min 52 settimani * | 2'019.41 EUR | 09.11.2023 |
NAV * | 2'521.07 EUR | 31.10.2024 |
Issue Price * | 2'521.07 EUR | 31.10.2024 |
Redemption Price * | 2'521.07 EUR | 31.10.2024 |
Closing Price * | ||
Prezzo minimo indicativo | ||
Attivo del fondo *** | 2'028'587'631 | |
Attivo della classe *** | 196'464'213 | |
Trading Information SIX |
Performance YTD | +9.88% |
29.12.2023 - 31.10.2024
29.12.2023 31.10.2024 |
---|---|---|
Performance YTD (in CHF) | +11.23% |
29.12.2023 - 31.10.2024
29.12.2023 31.10.2024 |
1 mese | -0.42% |
30.09.2024 - 31.10.2024
30.09.2024 31.10.2024 |
3 mesi | +4.67% |
31.07.2024 - 31.10.2024
31.07.2024 31.10.2024 |
6 mesi | +4.04% |
30.04.2024 - 31.10.2024
30.04.2024 31.10.2024 |
1 anno | +25.41% |
31.10.2023 - 31.10.2024
31.10.2023 31.10.2024 |
2 anni | +14.12% |
31.10.2022 - 31.10.2024
31.10.2022 31.10.2024 |
3 anni | -8.30% |
02.11.2021 - 31.10.2024
02.11.2021 31.10.2024 |
5 anni | +27.74% |
31.10.2019 - 31.10.2024
31.10.2019 31.10.2024 |
Quota di partecipazione al capitale in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Utile totale del fondo in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quota immobiliare in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 31.10.2024 |
Intuitive Surgical Inc | 9.92% | |
---|---|---|
Boston Scientific Corp | 9.81% | |
Stryker Corp | 9.72% | |
Abbott Laboratories | 9.71% | |
Medtronic PLC | 4.91% | |
Alcon Inc | 4.51% | |
Essilorluxottica | 4.21% | |
Becton Dickinson & Co | 4.03% | |
Hoya Corp | 3.93% | |
Edwards Lifesciences Corp | 3.44% | |
Ultimo aggiornamento dei dati | 30.09.2024 |
TER | 1.57% |
---|---|
Data TER | 28.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.56% |
SRRI ***
|
|
Data SRRI *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |